High pathologic complete remission rate with liposome-encapsulated doxorubicin plus paclitaxel plus trastuzumab as primary treatment in HER-2 positive operable breast cancer: clinical experience

被引：0
|
作者：
Gavila, J. [1 ]
Guerrero-Zotano, A. [1 ]
Climent, M. A. [1 ]
Blanch, S. [1 ]
Guillem, V. [1 ]
Camp, J. [1 ]
Tortajada, M. I. [1 ]
Gozalbo, F. [1 ]
Vidal, P. [1 ]
Ruiz, A. [1 ]
机构：
[1] Fdn Inst Valenciano Oncol, Valencia, Spain
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(10)70066-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：68 / 69
页数：2
相关论文
共 50 条
  • [21] Pilot trial of trastuzumab starting with or after the doxorubicin component of a doxorubicin plus paclitaxel regimen for women with HER2-positive advanced breast cancer
    Bianchi, G
    Albanell, J
    Eiermann, W
    Vitali, G
    Borquez, D
    Viganò, L
    Molina, R
    Raab, G
    Locatelli, A
    Vanhauwere, B
    Gianni, L
    Baselga, J
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 5944 - 5951
  • [22] A phase I study of interferon-gamma (γ) plus weekly paclitaxel, trastuzumab and pertuzumab in patients with HER-2 positive breast cancer
    Han, H. S.
    Khong, H.
    Costa, R.
    Loftus, L.
    Goodridge, D.
    Henry, T.
    Soliman, H.
    Ismail-Khan, R.
    Fridley, B.
    Czerniecki, B.
    CANCER RESEARCH, 2019, 79 (04)
  • [23] A phase 2 trial of myocet®, cyclophosphamide plus /- trastuzumab followed by weekly paclitaxel plus /- trastuzumab as primary systemic therapy in operable and locally advanced breast cancer
    Pistilli, B.
    Rossi, D.
    Benedetti, G.
    Baldelli, A. M.
    Decembrini-Cognigni, P.
    Casadei, V.
    Ciccioli, G.
    Ranaldi, R.
    Fiorentini, G.
    Latini, L.
    CANCER RESEARCH, 2013, 73
  • [24] Pathologic Complete Response to Neoadjuvant Chemotherapy Plus Trastuzumab Predicts for Improved Survival in Women With HER2-positive Breast Cancer
    Kim, M. M.
    Allen, P.
    Gonzalez-Angulo, A.
    Woodward, W. A.
    Meric-Bernstam, F.
    Buzdar, A. U.
    Hunt, K. K.
    Hortobagyi, G. N.
    Buchholz, T. A.
    Mittendorf, E. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S229 - S229
  • [25] Complete response after "neoadjuvant" pertuzumab plus trastuzumab plus docetaxel chemotherapy in Her2-positive breast cancer
    Lai-Tiong, F.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (05) : 836 - 837
  • [26] Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel–FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice
    Sonia Pernas
    Miguel Gil-Gil
    María Ochoa de Olza
    Anna Gumà
    Fina Climent
    Anna Petit
    María Jesús Pla
    Amparo García-Tejedor
    Ana López-Ojeda
    Cati Falo
    Adela Fernandez-Otega
    Carlos Mesia
    Francisco Javier Pérez-Martin
    Ander Urruticoechea
    Josep Ramon Germà
    Breast Cancer Research and Treatment, 2012, 134 : 1161 - 1168
  • [27] Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience
    Singh, Jasmeet C.
    Mamtani, Anita
    Barrio, Andrea
    Morrow, Monica
    Sugarman, Steven
    Jones, Lee W.
    Yu, Anthony F.
    Argolo, Daniel
    Smyth, Lilian M.
    Modi, Shanu
    Schweber, Sarah
    Boafo, Camilla
    Patil, Sujata
    Norton, Larry
    Baselga, Jose
    Hudis, Clifford A.
    Dang, Chau
    ONCOLOGIST, 2017, 22 (02): : 139 - 143
  • [28] Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer
    Yu, Anthony F.
    Manrique, Carlos
    Pun, Shawn
    Liu, Jennifer E.
    Mara, Elton
    Fleisher, Amartin
    Patil, Sujata
    Jones, Lee W.
    Steingart, Richard M.
    Hudis, Clifford A.
    Dang, Chau T.
    ONCOLOGIST, 2016, 21 (04): : 418 - 424
  • [29] INTRATHECAL TRASTUZUMAB TREATMENT OF HER-2 POSITIVE LEPTOMENINGEAL BREAST CANCER: THE UNIVERSITY OF MICHIGAN EXPERIENCE
    Peters, Kelsey
    Robell, Lindsay
    Morikawa, Aki
    Umemura, Yoshie
    Sun, Yilun
    Leung, Denise
    Mammoser, Aaron
    Gill, Anoop
    Junck, Larry
    NEURO-ONCOLOGY, 2020, 22 : 123 - 123
  • [30] Radiotherapy plus trastuzumab in the treatment of Her2-positive locally advanced breast cancer
    Belokhvostova, A.
    Ragulin, Y.
    ANNALS OF ONCOLOGY, 2015, 26
12345